Anodal tDCS plus virtual-reality exergaming for thinking problems in people with multiple sclerosis.
Official title: Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis: a Protocol of a Double Blind, Randomized, Prospective, Controlled Study.
Run by Ospedale Policlinico San Martino · NCT07114809 · Data updated 2026-11-12
This study will test whether adding mild brain stimulation (anodal tDCS) to virtual-reality exergaming can improve cognitive problems in adults with multiple sclerosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Ospedale Policlinico San Martino Academic / other |
| Locations | 3 sites (Genova, Italy and 2 other locations) |
| Status | Recruiting |
| Started | September 2, 2024 |
| Main results expected | January 2026 |
| Study ends | January 2026 |
| Registry record updated | August 11, 2025 |
| Trial ID | NCT07114809 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–60 with a confirmed MS diagnosis, cognitive impairment, and EDSS ≤ 7.5 who have no major psychiatric disorders, epilepsy, recent steroid-treated relapse, prior brain surgery, or severe bilateral visual loss are the intended participants.
✕Probably not a fit
People older than 60, with EDSS > 7.5, active epilepsy, recent MS relapse, major psychiatric disease, prior brain surgery, or poor bilateral vision are unlikely to be eligible or to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a double-blind, randomized, controlled study enrolling 80 people with multiple sclerosis and cognitive impairment, split into an experimental group and a sham-control group. All participants complete ten one-hour exergaming (non-immersive VR) sessions over two weeks, while the experimental group receives simultaneous anodal tDCS over the left dorsolateral prefrontal cortex and the control group receives sham stimulation. The anodal electrode is placed over the left DLPFC and the reference electrode over the right shoulder using a portable constant-current stimulator. Outcomes focus on changes in cognitive performance and related symptoms such as fatigue and quality of life.
Why it matters
Potential benefit: If successful, the combined tDCS and VR approach could improve thinking skills and reduce fatigue, offering a noninvasive add-on to existing rehabilitation for people with MS.
How similar studies have gone: Previous small studies of tDCS and of VR/exergaming in neurological conditions, including MS, have shown modest cognitive or functional benefits, but the simultaneous combination of anodal tDCS and VR is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. MS diagnosis according to McDonald's criteria (McDonald 2017); 2. age between 18 and 60 (to avoid participants with possible CI due to aging); 3) disability score ≤7.5 at the Expanded Disability Status Scale (EDSS, Kurtzke 1983). Exclusion Criteria: 1. subjects affected by major psychiatric disorders 2. epilepsy 3. previous brain surgery 4. MS relapse requiring steroid therapy in the previous two months 5. bilateral visual acuity \< 6/10
Where it's running
-
Azienda Sanitaria Genovese
Genova, Italy, Italy Recruiting -
Ospedale Policlinico San Martino - IRCCS
Genova, Italy, Italy Recruiting -
Italian multiple sclerosis foundation
Genova, Italy, Italy Recruiting
Study contacts
- Principal investigator: Laura Mori, MD, PhD — Ospedale Policlinico San Martino IRCCS
- Study coordinator: Laura Mori, MD, PhD
- Email: laura.mori@hsanmartino.it
- Phone: *39 010 555 5645
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating Modafinil's Effect on Cognitive Impairment in Multiple Sclerosis
This study is testing if modafinil can help improve thinking skills in adults with multiple sclerosis and see how brain activity might predict who benefits from the treatment.
-
Rehabilitation for balance and gait issues in multiple sclerosis patients using technology
This study is testing if a new robotic rehabilitation program can help people with multiple sclerosis improve their balance and walking over a year.
-
Using a robotic exoskeleton to help people with Multiple Sclerosis improve mobility and cognition
This study tests if using a robotic exoskeleton can help people with Multiple Sclerosis walk better and improve their memory and learning skills compared to regular therapy.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.